Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing.

Ryerson LZ, Foley J, Chang I, Kister I, Cutter G, Metzger RR, Goldberg JD, Li X, Riddle E, Smirnakis K, Kasliwal R, Ren Z, Hotermans C, Ho PR, Campbell N.

Neurology. 2019 Sep 12. pii: 10.1212/WNL.0000000000008243. doi: 10.1212/WNL.0000000000008243. [Epub ahead of print]

PMID:
31515290
2.

Pegylated Interferon Alfa-2a for Polycythemia Vera or Essential Thrombocythemia Resistant or Intolerant to Hydroxyurea.

Yacoub A, Mascarenhas J, Kosiorek H, Prchal JT, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Papaemmanuil E, Salama M, Singer-Weinberg R, Rampal R, Goldberg JD, Barbui T, Mesa R, Dueck AC, Hoffman R.

Blood. 2019 Sep 12. pii: blood.2019000428. doi: 10.1182/blood.2019000428. [Epub ahead of print]

PMID:
31515250
3.

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Mascarenhas J, Kosiorek H, Prchal J, Yacoub A, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Salama ME, Weinberg RS, Rampal R, Goldberg JD, Mesa R, Dueck AC, Hoffman R.

Leukemia. 2019 Jul 30. doi: 10.1038/s41375-019-0524-7. [Epub ahead of print] No abstract available.

PMID:
31363161
4.

Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients.

Formenti SC, Hawtin RE, Dixit N, Evensen E, Lee P, Goldberg JD, Li X, Vanpouille-Box C, Schaue D, McBride WH, Demaria S.

J Immunother Cancer. 2019 Jul 11;7(1):177. doi: 10.1186/s40425-019-0633-x.

5.

Plasma Zonulin Levels in Childhood Nephrotic Syndrome.

Trachtman H, Gipson DS, Lemley KV, Troost JP, Faul C, Morrison DJ, Vento SM, Ahn DH, Goldberg JD.

Front Pediatr. 2019 May 16;7:197. doi: 10.3389/fped.2019.00197. eCollection 2019.

6.

Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening.

Beauchamp KA, Taber KAJ, Grauman PV, Spurka L, Lim-Harashima J, Svenson A, Goldberg JD, Muzzey D.

Genet Med. 2019 May 15. doi: 10.1038/s41436-019-0543-9. [Epub ahead of print]

PMID:
31089271
7.

Sequencing as a first-line methodology for cystic fibrosis carrier screening.

Beauchamp KA, Johansen Taber KA, Grauman PV, Spurka L, Lim-Harashima J, Svenson A, Goldberg JD, Muzzey D.

Genet Med. 2019 Apr 30. doi: 10.1038/s41436-019-0525-y. [Epub ahead of print] Erratum in: Genet Med. 2019 May 15;:.

PMID:
31036917
8.

A data-driven evaluation of the size and content of expanded carrier screening panels.

Ben-Shachar R, Svenson A, Goldberg JD, Muzzey D.

Genet Med. 2019 Sep;21(9):1931-1939. doi: 10.1038/s41436-019-0466-5. Epub 2019 Feb 28.

PMID:
30816298
9.

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.

Mascarenhas J, Baer MR, Kessler C, Hexner E, Tremblay D, Price L, Sandy L, Weinberg R, Pahl H, Silverman LR, Goldberg JD, Kosiorek H, Dueck AC, Hoffman R.

Leuk Lymphoma. 2019 May;60(5):1343-1345. doi: 10.1080/10428194.2018.1532509. Epub 2019 Jan 22. No abstract available.

PMID:
30668266
10.

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.

Rampal RK, Mascarenhas JO, Kosiorek HE, Price L, Berenzon D, Hexner E, Abboud CN, Kremyanskaya M, Weinberg RS, Salama ME, Menghrajani K, Najfeld V, Sandy L, Heaney ML, Levine RL, Mesa RA, Dueck AC, Goldberg JD, Hoffman R.

Blood Adv. 2018 Dec 26;2(24):3572-3580. doi: 10.1182/bloodadvances.2018019661.

11.

Clinical utility of expanded carrier screening: results-guided actionability and outcomes.

Johansen Taber KA, Beauchamp KA, Lazarin GA, Muzzey D, Arjunan A, Goldberg JD.

Genet Med. 2019 May;21(5):1041-1048. doi: 10.1038/s41436-018-0321-0. Epub 2018 Oct 11.

PMID:
30310157
12.

Industry perspectives on prenatal genetic testing.

Swanson A, Goldberg JD.

Semin Perinatol. 2018 Aug;42(5):314-317. doi: 10.1053/j.semperi.2018.07.021. Epub 2018 Jul 26. Review.

PMID:
30241950
13.

Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis.

Domingues V, Levinson BA, Bornkamp N, Goldberg JD, Buyon J, Belmont HM.

Lupus Sci Med. 2018 Sep 4;5(1):e000271. doi: 10.1136/lupus-2018-000271. eCollection 2018.

14.

Hypofractionated Whole-Breast Irradiation in Women Less Than 50 Years Old Treated on 4 Prospective Protocols.

Shaikh F, Chew J, Hochman T, Purswani J, Maisonet O, Peat E, Huppert N, Cooper BT, Tam M, Goldberg JD, Perez CA, Formenti SC, Gerber NK.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1159-1167. doi: 10.1016/j.ijrobp.2018.04.034. Epub 2018 Apr 19.

PMID:
29859789
15.

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer.

Formenti SC, Lee P, Adams S, Goldberg JD, Li X, Xie MW, Ratikan JA, Felix C, Hwang L, Faull KF, Sayre JW, Hurvitz S, Glaspy JA, Comin-Anduix B, Demaria S, Schaue D, McBride WH.

Clin Cancer Res. 2018 Jun 1;24(11):2493-2504. doi: 10.1158/1078-0432.CCR-17-3322. Epub 2018 Feb 23.

16.

Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City.

Lin D, Goldberg JD, Hochman T, Levinson BA, Khan M, Newman E, Leichman LP, Gold HT.

Cancer Causes Control. 2018 Feb;29(2):253-260. doi: 10.1007/s10552-017-0996-6. Epub 2017 Dec 18.

PMID:
29250702
17.

Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.

Kwa M, Li X, Novik Y, Oratz R, Jhaveri K, Wu J, Gu P, Meyers M, Muggia F, Speyer J, Iwano A, Bonakdar M, Kozhaya L, Tavukcuoglu E, Budan B, Raad R, Goldberg JD, Unutmaz D, Adams S.

Breast Cancer Res Treat. 2018 Feb;168(1):57-67. doi: 10.1007/s10549-017-4570-4. Epub 2017 Nov 9.

PMID:
29124456
18.

A 20-channel magnetoencephalography system based on optically pumped magnetometers.

Borna A, Carter TR, Goldberg JD, Colombo AP, Jau YY, Berry C, McKay J, Stephen J, Weisend M, Schwindt PDD.

Phys Med Biol. 2017 Nov 10;62(23):8909-8923. doi: 10.1088/1361-6560/aa93d1.

19.

Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples.

Ghiossi CE, Goldberg JD, Haque IS, Lazarin GA, Wong KK.

J Genet Couns. 2018 Jun;27(3):616-625. doi: 10.1007/s10897-017-0160-1. Epub 2017 Sep 27.

20.

Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.

Rule S, Dreyling M, Goy A, Hess G, Auer R, Kahl B, Cavazos N, Liu B, Yang S, Clow F, Goldberg JD, Beaupre D, Vermeulen J, Wildgust M, Wang M.

Br J Haematol. 2017 Nov;179(3):430-438. doi: 10.1111/bjh.14870. Epub 2017 Aug 18.

21.

Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort.

Hasanaj L, Thawani SP, Webb N, Drattell JD, Serrano L, Nolan RC, Raynowska J, Hudson TE, Rizzo JR, Dai W, McComb B, Goldberg JD, Rucker JC, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2018 Mar;38(1):24-29. doi: 10.1097/WNO.0000000000000533.

22.

Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters.

Cooper BT, Li X, Shin SM, Modrek AS, Hsu HC, DeWyngaert JK, Jozsef G, Lymberis SC, Goldberg JD, Formenti SC.

Adv Radiat Oncol. 2016 Aug 9;1(4):373-381. doi: 10.1016/j.adro.2016.08.001. eCollection 2016 Oct-Dec.

23.

Response to "Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods".

Muzzey D, Haverty C, Evans EA, Goldberg JD.

Prenat Diagn. 2017 Jul;37(7):727-728. doi: 10.1002/pd.5071. No abstract available.

24.

Systematic design and comparison of expanded carrier screening panels.

Beauchamp KA, Muzzey D, Wong KK, Hogan GJ, Karimi K, Candille SI, Mehta N, Mar-Heyming R, Kaseniit KE, Kang HP, Evans EA, Goldberg JD, Lazarin GA, Haque IS.

Genet Med. 2018 Jan;20(1):55-63. doi: 10.1038/gim.2017.69. Epub 2017 Jun 22.

25.

Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus.

Hess G, Rule S, Jurczak W, Jerkeman M, Santucci Silva R, Rusconi C, Caballero D, Joao C, Witzens-Harig M, Bence-Bruckler I, Cho SG, Zhou W, Goldberg JD, Trambitas C, Enny C, Vermeulen J, Traina S, Chiou CF, Diels J, Dreyling M.

Leuk Lymphoma. 2017 Dec;58(12):2824-2832. doi: 10.1080/10428194.2017.1326034. Epub 2017 May 30.

PMID:
28556689
26.

Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.

Formenti SC, Golden EB, Goldberg JD, Li X, Taff J, Fenton-Kerimian MB, Chandrasekhar S, Demaria S, Novik Y.

Oncoimmunology. 2016 Dec 27;6(3):e1274479. doi: 10.1080/2162402X.2016.1274479. eCollection 2017.

27.

Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.

Artieri CG, Haverty C, Evans EA, Goldberg JD, Haque IS, Yaron Y, Muzzey D.

Prenat Diagn. 2017 May;37(5):482-490. doi: 10.1002/pd.5036. Epub 2017 Apr 26.

PMID:
28317136
28.

Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates.

Lazarin GA, Haque IS, Evans EA, Goldberg JD.

Prenat Diagn. 2017 Apr;37(4):350-355. doi: 10.1002/pd.5018. Epub 2017 Mar 9.

29.

Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.

Goldberg JD, Zheng J, Ratan R, Small TN, Lai KC, Boulad F, Castro-Malaspina H, Giralt SA, Jakubowski AA, Kernan NA, O'Reilly RJ, Papadopoulos EB, Young JW, van den Brink MR, Heller G, Perales MA.

Leuk Lymphoma. 2017 Aug;58(8):1859-1871. doi: 10.1080/10428194.2016.1265113. Epub 2017 Jan 10.

30.

Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.

Barba P, Hilden P, Devlin SM, Maloy M, Dierov D, Nieves J, Garrett MD, Sogani J, Cho C, Barker JN, Kernan NA, Castro-Malaspina H, Jakubowski AA, Koehne G, Papadopoulos EB, Prockop S, Sauter C, Tamari R, van den Brink MR, Avecilla ST, Meagher R, O'Reilly RJ, Goldberg JD, Young JW, Giralt S, Perales MA, Ponce DM.

Biol Blood Marrow Transplant. 2017 Mar;23(3):452-458. doi: 10.1016/j.bbmt.2016.12.633. Epub 2016 Dec 23.

31.

Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer.

Musa F, Pothuri B, Blank SV, Ling HT, Speyer JL, Curtin J, Boyd L, Li X, Goldberg JD, Muggia F, Tiersten A.

Gynecol Oncol. 2017 Feb;144(2):279-284. doi: 10.1016/j.ygyno.2016.11.043. Epub 2016 Dec 5.

PMID:
27931751
32.

A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF).

Mascarenhas J, Sandy L, Lu M, Yoon J, Petersen B, Zhang D, Ye F, Newsom C, Najfeld V, Hochman T, Goldberg JD, Hoffman R.

Leuk Res. 2017 Feb;53:13-19. doi: 10.1016/j.leukres.2016.11.015. Epub 2016 Nov 30.

PMID:
27930945
33.

Multifocal Invasive Ductal Cancer: Distinguishing Independent Tumor Foci From Multiple Satellites.

Alexander M, Acosta Gonzalez G, Malerba S, Hochman T, Goldberg JD, Darvishian F.

Int J Surg Pathol. 2017 Jun;25(4):298-303. doi: 10.1177/1066896916676586. Epub 2016 Nov 10.

PMID:
27831532
34.

Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.

Haque IS, Lazarin GA, Kang HP, Evans EA, Goldberg JD, Wapner RJ.

JAMA. 2016 Aug 16;316(7):734-42. doi: 10.1001/jama.2016.11139.

PMID:
27533158
35.

Re: Carrier Screening is a Deficient Strategy for Determining Sperm Donor Eligibility and Reducing Risk of Disease in Recipient Children (From: Silver AJ, Larson JL, Silver MJ, et al. Genet Test Mol Biomarkers 2016;20:276-284).

Wong KK, Goldberg JD, Evans EA, Kang HP, Haque IS.

Genet Test Mol Biomarkers. 2016 Aug;20(8):413-4. doi: 10.1089/gtmb.2016.29019.kkw. No abstract available.

PMID:
27505438
36.

Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed.

Cooper BT, Formenti-Ujlaki GF, Li X, Shin SM, Fenton-Kerimian M, Guth A, Roses DF, Hitchen CJ, Rosenstein BS, Dewyngaert JK, Goldberg JD, Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):571-8. doi: 10.1016/j.ijrobp.2015.12.373. Epub 2015 Dec 29.

PMID:
27131077
37.

Quality of Life in Women Undergoing Breast Irradiation in a Randomized, Controlled Clinical Trial Evaluating Different Tumor Bed Boost Fractionations.

Finkel MA, Cooper BT, Li X, Fenton-Kerimian M, Goldberg JD, Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):579-89. doi: 10.1016/j.ijrobp.2016.02.004. Epub 2016 Feb 6.

PMID:
27045811
38.

A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation.

Hobbs GS, Kaur N, Hilden P, Ponce D, Cho C, Castro-Malaspina HR, Giralt S, Goldberg JD, Jakubowski AA, Papadopoulos EB, Sauter C, Koehne G, Yahalom J, Delvin S, Barker JN, Perales MA.

Bone Marrow Transplant. 2016 Jul;51(7):1010-2. doi: 10.1038/bmt.2016.36. Epub 2016 Mar 14. No abstract available.

39.

Current controversies in traditional and expanded carrier screening.

Lazarin GA, Goldberg JD.

Curr Opin Obstet Gynecol. 2016 Apr;28(2):136-41. doi: 10.1097/GCO.0000000000000256. Review.

PMID:
26844860
40.

Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.

Jhaveri K, Teplinsky E, Silvera D, Valeta-Magara A, Arju R, Giashuddin S, Sarfraz Y, Alexander M, Darvishian F, Levine PH, Hashmi S, Zolfaghari L, Hoffman HJ, Singh B, Goldberg JD, Hochman T, Formenti S, Esteva FJ, Moran MS, Schneider RJ.

Clin Breast Cancer. 2016 Apr;16(2):113-22.e1. doi: 10.1016/j.clbc.2015.11.006. Epub 2015 Dec 1.

41.

Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: Background review of the literature.

DeCotiis C, Hu Y, Greenberg AK, Huie M, Tsay JC, Pass H, Goldberg JD, Rom WN.

Cancer Biomark. 2016;16(2):219-33. doi: 10.3233/CBM-150559. Review.

PMID:
26756613
42.

Introduction.

Wapner RJ, Goldberg JD.

Semin Perinatol. 2016 Feb;40(1):1-2. doi: 10.1053/j.semperi.2015.11.001. Epub 2015 Dec 22. No abstract available.

PMID:
26726137
43.

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.

Dreyling M, Jurczak W, Jerkeman M, Silva RS, Rusconi C, Trneny M, Offner F, Caballero D, Joao C, Witzens-Harig M, Hess G, Bence-Bruckler I, Cho SG, Bothos J, Goldberg JD, Enny C, Traina S, Balasubramanian S, Bandyopadhyay N, Sun S, Vermeulen J, Rizo A, Rule S.

Lancet. 2016 Feb 20;387(10020):770-8. doi: 10.1016/S0140-6736(15)00667-4. Epub 2015 Dec 7. Erratum in: Lancet. 2016 Feb 20;387(10020):750.

PMID:
26673811
44.

Single-item migraine screening tests, self-reported bothersome headache or stripe pattern hypersensitivity?

Yuan H, Hopkins M, Goldberg JD, Silberstein SD.

Acta Neurol Scand. 2016 Oct;134(4):277-83. doi: 10.1111/ane.12539. Epub 2015 Dec 1.

PMID:
26626126
45.

Cell cycle features of C. elegans germline stem/progenitor cells vary temporally and spatially.

Roy D, Michaelson D, Hochman T, Santella A, Bao Z, Goldberg JD, Hubbard EJA.

Dev Biol. 2016 Jan 1;409(1):261-271. doi: 10.1016/j.ydbio.2015.10.031. Epub 2015 Nov 11.

46.

CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.

Tamari R, Chung SS, Papadopoulos EB, Jakubowski AA, Hilden P, Devlin SM, Goldberg JD, Perales MA, Ponce DM, Sauter CS, Maloy MA, Herman DY, Klimek V, Young JW, O'Reilly RJ, Giralt SA, Castro-Malaspina H.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2106-2114. doi: 10.1016/j.bbmt.2015.07.010. Epub 2015 Jul 14.

47.

Changing trends in carrier screening for genetic disease in the United States.

Nazareth SB, Lazarin GA, Goldberg JD.

Prenat Diagn. 2015 Oct;35(10):931-5. doi: 10.1002/pd.4647. Epub 2015 Jul 27. Review.

48.

Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells.

Lu M, Xia L, Liu YC, Hochman T, Bizzari L, Aruch D, Lew J, Weinberg R, Goldberg JD, Hoffman R.

Blood. 2015 Aug 20;126(8):972-82. doi: 10.1182/blood-2014-12-618595. Epub 2015 May 28.

49.

Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework.

Mazumdar M, Messinger S, Finkelstein DM, Goldberg JD, Lindsell CJ, Morton SC, Pollock BH, Rahbar MH, Welty LJ, Parker RA; Biostatistics, Epidemiology, and Research Design (BERD) Key Function Committee of the Clinical and Translational Science Awards (CTSA) Consortium.

Acad Med. 2015 Oct;90(10):1302-8. doi: 10.1097/ACM.0000000000000759.

50.

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, Docampo MD, Peled JU, Arpaia N, Cross JR, Peets TK, Lumish MA, Shono Y, Dudakov JA, Poeck H, Hanash AM, Barker JN, Perales MA, Giralt SA, Pamer EG, van den Brink MR.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1373-83. doi: 10.1016/j.bbmt.2015.04.016. Epub 2015 May 11.

Supplemental Content

Loading ...
Support Center